Marshall R. Posner

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

Marshall R. Posner, Diáne Hershock, C. Blajman et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text

Medicine, Oncology, Chemotherapy +8

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection

Timothy W. Baba, Vladimír Liška, Regina Hofmann‐Lehmann et al. · Nature Medicine · 2000 · 857 citations

Life Sciences, Immunology, Infectious Diseases +12

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial

Robert I. Haddad, Anne O’Neill, Guilherme Rabinowits et al. · The Lancet Oncology · 2013 · 747 citations

Medicine, Oncology, Radiation Oncology +14

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial

Marshall R. Posner, Jochen H. Lorch, Olga Goloubeva et al. · Annals of Oncology · 2011 · 487 citations · Full text

Medicine, Oncology, Molecular Oncology +7

Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer

John Nemunaitis, Fadlo R. Khuri, Ian Ganly et al. · Journal of Clinical Oncology · 2001 · 474 citations · Full text

Life Sciences, Immunology, Oncology +17